Blog

Behind the Science: Meet Liz Culyba, Our Associate Scientific Director  At Immunologix Laboratories, we believe that groundbreaking science is powered by passionate individuals—each with a unique story of discovery.  Today, we’re launching our “What Is Your Why?” series, bringing the human element to scientific innovation. Our first feature introduces Liz Culyba, whose journey from aspiring…

In our latest deep dive article, we examine the Immunologix difference through our comprehensive bioanalytical intake process for large molecule program support. We detail our scientific triad model, where every project benefits from three dedicated scientists bringing 30+ years of combined expertise to bear on complex analytical challenges. Beyond traditional project management, our approach creates…

At Immunologix Laboratories, we provide integrated laboratory and scientific services for drug development by combining advanced laboratory capabilities with translational expertise. Since our founding in 2012, we have built an organization that integrates laboratory services with strategic drug development knowledge through our scientific triad model, where each project team includes a Principal Investigator, Translational Scientist,…

Key Learnings The landscape of drug development is dynamic, and innovative drug modalities like exosomes can present unique challenges that require both expertise and adaptability in bioanalytical assay development. In this blog, we showcase how our team tackled these challenges with Drug B, an exosome-based therapy targeting T cells and natural killer cells for lymphoma…